作者: G. Wu , W. Yang , R. F. Barth , S. Kawabata , M. Swindall
DOI: 10.1158/1078-0432.CCR-06-2399
关键词: Growth factor 、 Sodium Borocaptate 、 Cetuximab 、 In vitro 、 Cancer research 、 Epidermal growth factor receptor 、 Growth factor receptor 、 Immunology 、 Glioma 、 Monoclonal antibody 、 Chemistry
摘要: Purpose: The purpose of the present study was to evaluate the anti–epidermal growth factor monoclonal antibody (mAb) cetuximab (IMC-C225) as a delivery agent for boron neutron …